Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(406)
•••
Comment by gebremeskelon Sep 25, 2019 11:28am
122 Views
Post# 30163026

RE:RE:RE:What if

RE:RE:RE:What ifThat's quite a claim!

Either you are an insider and know what goes om behind closed doors at Theralase or you are a dumb@ss basher blowhard trying his best  to churn up a little extra ill-will against the company.

I favour the latter interpretation.

Vindicator00001 wrote: Laser - this meaningless conjecture on the supposed BOD nominee on the "What ifs" and political BS is camo for the fact that the price can't move until the financing and CEO drive-thru on the option wagon are well in the rearview mirror. News will have to wait. Chew on the analyst report and some fluffy articles here until then. Sorry, did I say CEO? I meant VP of Business Development and the woman he sleeps next to took millions while the CEO's (yes not 1 but 2) got a pittance. I love the set up. Not one but two CEO's report to the VP of business development and his wife. Super perfect org structure for a public company. What could go wrong here?


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities